Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial

Abstract Background The effectiveness of biologic therapies, primarily tumor necrosis factor inhibitors (TNFi), for children with spondyloarthritis (SpA) has made inactive disease a realistic patient outcome. However, biologic therapies are costly, primarily delivered by subcutaneous or intravenous...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Pamela F. Weiss, Cora E. Sears, Timothy G. Brandon, Christopher B. Forrest, Emily Neu, Melanie Kohlheim, Jenny Leal, Rui Xiao, Daniel Lovell
פורמט: Article
שפה:English
יצא לאור: BMC 2023-02-01
סדרה:Trials
נושאים:
גישה מקוונת:https://doi.org/10.1186/s13063-022-07038-6